Aleafia Health’s (ALEF.T) subsidiary, Emblem Germany GmbH, has submitted its application to German regulators for European Union good manufacturing practice certification (EU-GMP) for their Paris facility buildout. The company’s…
Emblem Cannabis
Weed stocks have been in down cycles before, but have always traditionally had sustained periods of irrational exuberance shortly thereafter, so folks would be forgiven for viewing the current…
This past Wednesday, Emblem (EMC.V) released its second quarter financials with some impressive numbers. Emblem has been on a tear since last week which proves that this sector still…
Well that didn’t take long. Just a day after we wrote an article excoriating Emblem Canabis (EMC.V) for sitting on their hands with news for the last year, new…
We have had a love/hate relationship with Emblem Cannabis (EMC.V) since it appeared on the Canadian cannabis markets. We liked that they were clients of ours when they went…
This article is part of an ongoing series that uses company documents to break apart and visualize data relating to the Canadian cannabis producer market. We’ve noted a few…
Let’s recap: September, we said it was a good time to buy into weed stocks. It was. December, we said it was a good time to take some profits…
On a normal day, the S&P/TSX composite index trades about 300 million shares. On December 27, 2017, in the traditional post-Christmas lull – with many brokers still stumbling home from…
Nothing infuriates the retail investor more than holding a stock with faith and hope as it drifts downward for months, with the company not doing anything to halt the…
If you’re wondering why your Aphria (APH.T) stock lost 13.8% today, you can blame the TSX – again. The Toronto Stock Exchange will contact all companies that cultivate, distribute…